IP Library › Assignment 051944/0026
Patent Assignment
Reel/Frame 051944/0026

Change of Name

Recorded: 2020-02-14 Pages: 15
Assignor
SELVITA S.A.
Executed: 2019-10-01
Assignee
RYVU THERAPEUTICS S.A.
UL. BOBRZYNSKIEGO 14, KRAKÓW, 30-348, POLAND
Covered Properties (2)
Novel Benzimidazole Derivatives as Kinase Inhibitors
Patent: 9,388,192 →
Application: 14/654,779 →
Publication: US 2015/0336967
Benzimidazole Derivatives as Kinase Inhibitors
Application: 15/179,601 →
Publication: US 2017/0152249
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 20, 2015
From: CZARDYBON, WOJCIECH; BRZÓZKA, KRZYSZTOF; GALEZOWSKI, MICHAL; WINDAK, RENATA
To: SELVITA SA
Reel/Frame 036382/0291 →
License Oct 19, 2017
From: SELVITA S.A.
To: BERLIN-CHEMIE AG
Reel/Frame 043901/0435 →
License Oct 24, 2017
From: SELVITA S.A.
To: BERLIN-CHEMIE AG
Reel/Frame 043936/0704 →
Assignment of Assignor's Interest Jul 25, 2018
From: CZARDYBON, WOJCIECH; BRZÓZKA, KRZYSZTOF; GALEZOWSKI, MICHAL; WINDAK, RENATA
To: SELVITA S.A.
Reel/Frame 046458/0758 →